Labelling requirements for the International Harmonisation of Ingredient Names project
Ingredients included in the International Harmonisation of Ingredients Name (IHIN) project have labelling and packaging requirements.
Latest articles
-
What do I need to do if my medicine or medical device is recalled?
Like all goods available in Australia, therapeutic goods can sometimes experience problems. When this happens, we decide if a ‘market action’ is needed. A market action aims to correct the problem. There are four types of market actions you should be aware of. -
More medicines begin transition to sole ingredient names soon
The dual labelling period for some medicine ingredients is ending on 30 April 2025. -
Updates to requirements and guidance for labels of injectable medicines
Find out about new requirements for labels of injectable electrolyte medicines and updates to guidance for medicine sponsors.
Latest consultations
-
We are seeking feedback on the proposed temporary labelling exemptions for paracetamol.
-
Have your say about proposed changes to address 3 medicine safety matters needing action, before we review labelling rules more broadly.
-
The TGA is seeking views on ingredient names that must be displayed as both the old and new ingredient name on medicine labels.